Abstract
Renal carcinoma in male Syrian hamsters, induced by chronic administration of estradiol for 5–7 months, is known to arise in the cortex at the cortico-medullary junction. In this in vivo model for hormonal carcinogenesis, estrogen-induced covalent DNA adducts have previously been observed in whole kidney and have been postulated to be involved in tumor induction. In the present study, the intrarenal distribution of estrogen-induced DNA modification and estrogen metabolizing enzymes were investigated in male Syrian hamsters to ascertain a role of metabolism and adduct formation in estrogen-induced carcinogenesis. The highest estrogen-induced DNA adduct concentrations as measured by 32P-postlabeling analysis were found in the renal cortex of hamsters treated with estradiol for 7 months. Total adduct levels in medullary DNA were approximately one-half of those found in cortex. Cytochrome P-450 enzymes were detected only in microsomes of kidney cortex (approximately 0.8 ± 0.6 nmol P-450/mg protein) but not medulla of untreated male Syrian hamsters. Prostaglandin endoperoxide synthase activity in kidney cortical microsomes was ⅕ of the activity found in medullary microsomes. Thus, microsomal cytochrome P-450 levels and estrogen-induced DNA adduct formation were highest in hamster kidney cortex, the origin of renal tumorigenesis. It is postulated that estrogen metabolism by cytochrome P-450 enzymes leading to covalent DNA modification plays a role in hormonal carcinogenesis in the hamster kidney.
Footnotes
-
↵1 Financial support was provided by the NIH, National Cancer Institute (Grants CA-43232, CA-43233, CA-32157 and CA-10893) and National Institute of Neurological and Communicative Disorders and Stroke (Grants K04-NS00873 and P01-NS-8494).
-
↵2 To whom requests for reprints should be addressed, at Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77550.
- Received August 25, 1986.
- Revision received December 17, 1986.
- Accepted January 5, 1987.
- ©1987 American Association for Cancer Research.